1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide

C26H24ClN7O2 — CID 122292483

IUPAC1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide
SMILESCc1cc(C)n(-c2ccc(Nc3ccc(NC(=O)C4CC(=O)N(c5ccc(Cl)cc5)C4)cc3)nn2)n1
InChIInChI=1S/C26H24ClN7O2/c1-16-13-17(2)34(32-16)24-12-11-23(30-31-24)28-20-5-7-21(8-6-20)29-26(36)18-14-25(35)33(15-18)22-9-3-19(27)4-10-22/h3-13,18H,14-15H2,1-2H3,(H,28,30)(H,29,36)
InChIKeyUOGBDQALFHYSNV-UHFFFAOYSA-N
MW501.98 g/mol
LogP4.67
Rot. Bonds6

About 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide

1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide (PubChem CID 122292483) has the molecular formula C26H24ClN7O2 and a molecular weight of 501.98 g/mol. Its IUPAC name is 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide.

Molecular Properties

Compound Name1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide
PubChem CID122292483
Molecular FormulaC26H24ClN7O2
Molecular Weight501.98 g/mol
Exact Mass501.17
IUPAC Name1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide
SMILESCc1cc(C)n(-c2ccc(Nc3ccc(NC(=O)C4CC(=O)N(c5ccc(Cl)cc5)C4)cc3)nn2)n1
InChIInChI=1S/C26H24ClN7O2/c1-16-13-17(2)34(32-16)24-12-11-23(30-31-24)28-20-5-7-21(8-6-20)29-26(36)18-14-25(35)33(15-18)22-9-3-19(27)4-10-22/h3-13,18H,14-15H2,1-2H3,(H,28,30)(H,29,36)
InChIKeyUOGBDQALFHYSNV-UHFFFAOYSA-N
XLogP4.67
TPSA105.04 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500501.98
LogP ≤ 54.67
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide?
The IUPAC name of 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide (CID 122292483) is 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide.
What is the SMILES notation for 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide?
The canonical SMILES for 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide is Cc1cc(C)n(-c2ccc(Nc3ccc(NC(=O)C4CC(=O)N(c5ccc(Cl)cc5)C4)cc3)nn2)n1.
What is the InChIKey of 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide?
The InChIKey is UOGBDQALFHYSNV-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24ClN7O2/c1-16-13-17(2)34(32-16)24-12-11-23(30-31-24)28-20-5-7-21(8-6-20)29-26(36)18-14-25(35)33(15-18)22-9-3-19(27)4-10-22/h3-13,18H,14-15H2,1-2H3,(H,28,30)(H,29,36).
What are the key properties of 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide?
1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide has a molecular weight of 501.98 g/mol, XLogP of 4.67, 6 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(4-chlorophenyl)-N-[4-[[6-(3,5-dimethylpyrazol-1-yl)pyridazin-3-yl]amino]phenyl]-5-oxopyrrolidine-3-carboxamide is sourced from PubChem (CID 122292483), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).